Kay Olmstead co-founded a non-profit organization CARER Group which stands for Catalyzing Access to Research and Equity in Representation. The mission of CARER group is health equity for everyone, and one of their main projects is to promote clinical trial diversity.
Kay is also a founder and CEO of Nano PharmaSolutions. Dr. Olmstead has over 31 years of experience in pharmaceutical industry with drugs approved by FDA and one in Europe.
Dr. Olmstead has published more than 12 manuscripts and has 11 issued patents and 3 pending patent applications. Dr. Olmstead received Ph.D. degree in Organic Chemistry at Johns Hopkins University followed by a NIH post-doctoral fellowship at Stanford University.
